Pei Jye Voon

5.6k total citations
28 papers, 199 citations indexed

About

Pei Jye Voon is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Pei Jye Voon has authored 28 papers receiving a total of 199 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 6 papers in Surgery. Recurrent topics in Pei Jye Voon's work include Lung Cancer Treatments and Mutations (8 papers), Gastric Cancer Management and Outcomes (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Pei Jye Voon is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Gastric Cancer Management and Outcomes (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Pei Jye Voon collaborates with scholars based in Malaysia, United States and Singapore. Pei Jye Voon's co-authors include Helen Mann, Suresh S. Ramalingam, Takayasu Kurata, Fumio Imamura, Caicun Zhou, Byoung Chul Cho, Jong Seok Lee, Virote Sriuranpong, Thanyanan Reungwetwattana and Isamu Okamoto and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Scientific Reports.

In The Last Decade

Pei Jye Voon

19 papers receiving 197 citations

Peers

Countries citing papers authored by Pei Jye Voon

Since Specialization

Citations

This map shows the geographic impact of Pei Jye Voon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei Jye Voon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei Jye Voon more than expected).

Fields of papers citing papers by Pei Jye Voon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pei Jye Voon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei Jye Voon. The network helps show where Pei Jye Voon may publish in the future.

Co-authorship network of co-authors of Pei Jye Voon

This figure shows the co-authorship network connecting the top 25 collaborators of Pei Jye Voon. A scholar is included among the top collaborators of Pei Jye Voon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pei Jye Voon. Pei Jye Voon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Amivantamab plus FOLFOX or FOLFIRI in RAS/BRAF wild-type metastatic colorectal cancer: Long-term follow-up from the phase 1b/2 OrigAMI-1 study. 2026 ·Journal of Clinical Oncology ·Eric Xueyu Chen, Rozita Abdul Malik, Yu‐Li Su, Pei Jye Voon, (unknown), Dirk Arnold, J. Randolph Hecht, (unknown), (unknown), (unknown), Sreenivasa R Chandana, (unknown), Sanjib Chowdhury, (unknown), (unknown), Mahesh Daksh, (unknown), Seema Sethi, (unknown)	0
2	Osimertinib long-term tolerability in patients with EGFRm NSCLC enrolled in the AURA program or FLAURA study 2025 ·Lung Cancer ·Marina Chiara Garassino, Yong He, Myung‐Ju Ahn, Sergey Orlov, Vanessa Potter, Terufumi Kato, Janessa Laskin, Pei Jye Voon, Thanyanan Reungwetwattana, Suresh S. Ramalingam, Yi‐Long Wu, Muna Albayaty, (unknown), Xiangning Huang, (unknown), Byoung Chul Cho	0
3	A comparison of clinical guidelines, treatment characteristics and outcomes in small cell lung cancer between East Asia and Europe/North America 2025 ·Frontiers in Oncology ·Chi‐Lu Chiang, Ross A. Soo, Tony Mok, Pei Jye Voon, (unknown), Ying Cheng, Hidehito Horinouchi, Byoung Chul Cho, Kang Xu, Myung‐Ju Ahn	0
4	Novel Therapeutic Strategies for Squamous Cell Carcinoma of the Head and Neck: Beyond EGFR and Checkpoint Blockade 2025 ·Biomedicines ·(unknown), Pei Jye Voon, (unknown), Wan‐Teck Lim	0
5	Survey of willingness to participate in clinical trials and influencing factors among cancer and non-cancer patients 2025 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), Mohamad Adam Bujang, Pei Jye Voon	1
6	Subcutaneous amivantamab and lazertinib as first-line treatment in patients with EGFR-mutated, advanced non-small cell lung cancer (NSCLC): Results from the phase 2 PALOMA-2 study. 2024 ·Journal of Clinical Oncology ·Sun Min Lim, (unknown), Josiane Mourão Dias, Pei Jye Voon, Soon Hin How, Xiangdong Zhou, (unknown), Bartomeu Massutí, Louise Medley, Misako Nagasaka, David Vicente, Nicolas Girard, Achim Rittmeyer, Dana‐Adriana Botesteanu, Ali Alhadab, Janine Mahoney, Yuehua Zhang, Joshua Bauml, Mahadi Baig, Susan C. Scott	3
7	Identification of phenomic data in the pathogenesis of cancers of the gastrointestinal (GI) tract in the UK biobank 2024 ·Scientific Reports ·(unknown), (unknown), Mohamad Adam Bujang, (unknown), Pei Jye Voon, Edmund Ui‐Hang Sim	2
8	Nasopharyngeal carcinoma in Sarawak : a 10-year review and update 2024 ·European Archives of Oto-Rhino-Laryngology ·(unknown), (unknown), (unknown), (unknown), Pei Jye Voon, Ing Ping Tang	0
9	Barriers And Challenges Of Multidisciplinary Teams In Oncology Management: A Scoping Review Protocol 2024 ·BMJ Open ·(unknown), (unknown), (unknown), (unknown), Daniel J. Lee, Pei Jye Voon	5
10	Peripheral transbronchial needle aspiration-guided pinpoint cryobiopsy of lung nodule without bronchus sign: A case report 2023 ·Respiratory Investigation ·Sze Shyang Kho, (unknown), (unknown), (unknown), (unknown), Pei Jye Voon, (unknown)	1
11	International Collaboration on Palliative Care Development Between ASCO and the Land of Hornbills 2023 ·JCO Global Oncology ·(unknown), (unknown), (unknown), Frank D. Ferris, (unknown), (unknown), (unknown), Asri Said, (unknown), (unknown), Pei Jye Voon, (unknown)	2
12	Development and validation of Join Clinical Trial Questionnaire (JoinCT) 2023 ·Asia-Pacific Journal of Clinical Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mohamad Adam Bujang, Pei Jye Voon	1
13	Real-world clinical practice and outcomes in treating stage III non-small cell lung cancer: KINDLE-Asia subset 2023 ·Frontiers in Oncology ·Kumar Prabhash, Daniel S.W. Tan, Ross A. Soo, Piyada Sitthideatphaiboon, (unknown), Pei Jye Voon, Elisna Syahruddin, (unknown), Reto Huggenberger, Byoung Chul Cho	2
14	Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction 2022 ·Journal of Experimental & Clinical Cancer Research ·Pei Jye Voon, Eric X. Chen, Helen X. Chen, A. Craig Lockhart, Solmaz Sahebjam, Karen Kelly, Ulka N. Vaishampayan, Vivek Subbiah, Albiruni R. Abdul Razak, Daniel J. Renouf, Sébastien J. Hotte, Arti Singh, Philippe L. Bédard, Aaron R. Hansen, S. Percy Ivy, Lisa Wang, (unknown), Lillian L. Siu, Anna Spreafico	7
15	Abstract P035: A phase 1 pharmacokinetic trial of single agent trametinib a MEK inhibitor in advanced cancer patients with hepatic dysfunction: An NCI Organ Dysfunction Working Group (ODWG) study (NCI 9591) 2021 ·Molecular Cancer Therapeutics ·Pei Jye Voon, Eric X. Chen, Helen X. Chen, A. Craig Lockhart, Solmaz Sahebjam, Karen Kelly, Ulka N. Vaishampayan, Vivek Subbiah, Albiruni R. Abdul Razak, Daniel J. Renouf, Sébastien J. Hotte, Arti Singh, Philippe L. Bédard, Aaron R. Hansen, (unknown), Lisa Wang, (unknown), Lillian L. Siu, Anna Spreafico	1
16	Exploration of Patient-Related Barriers to Effective Cancer Pain Management in a Diverse Multicultural Developing Country 2020 ·Journal of Pain and Symptom Management ·(unknown), (unknown), Pei Jye Voon	3
17	A 4-year review of surgical and oncological outcomes of endoscopic endonasal transpterygoid nasopharyngectomy in salvaging locally recurrent nasopharyngeal carcinoma 2019 ·European Archives of Oto-Rhino-Laryngology ·Ing Ping Tang, (unknown), (unknown), (unknown), Pei Jye Voon, (unknown), Narayanan Prepageran, Ricardo L. Carrau	9
18	Osimertinib versus Standard of Care EGFR TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC: FLAURA Asian Subset 2018 ·Journal of Thoracic Oncology ·Byoung Chul Cho, (unknown), Ki Hyeong Lee, Arunee Dechaphunkul, Virote Sriuranpong, Fumio Imamura, Naoyuki Nogami, Takayasu Kurata, Isamu Okamoto, Caicun Zhou, Ying Cheng, Eun Kyung Cho, Pei Jye Voon, Jong Seok Lee, Helen Mann, Matilde Saggese, Thanyanan Reungwetwattana, Suresh S. Ramalingam, Yuichiro Ohe	93
19	Unusual Cause of a Massive Abdominal Cystic Tumor 2012 ·Gastroenterology ·Esther Ng, Sarika Gupta, Pei Jye Voon	0
20	Tumour Genetics and Genomics to Personalise Cancer Treatment 2011 ·Annals of the Academy of Medicine Singapore ·Pei Jye Voon, (unknown)	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact